AU4994600A - Bacteriophage isolated from bacterial genomes and extrachromosomal elements and methods of use thereof - Google Patents

Bacteriophage isolated from bacterial genomes and extrachromosomal elements and methods of use thereof

Info

Publication number
AU4994600A
AU4994600A AU49946/00A AU4994600A AU4994600A AU 4994600 A AU4994600 A AU 4994600A AU 49946/00 A AU49946/00 A AU 49946/00A AU 4994600 A AU4994600 A AU 4994600A AU 4994600 A AU4994600 A AU 4994600A
Authority
AU
Australia
Prior art keywords
methods
bacterial genomes
extrachromosomal elements
bacteriophage isolated
bacteriophage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU49946/00A
Inventor
David K. R. Karaolis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Maryland at Baltimore
Original Assignee
University of Maryland at Baltimore
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Maryland at Baltimore filed Critical University of Maryland at Baltimore
Publication of AU4994600A publication Critical patent/AU4994600A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/13—Tumour cells, irrespective of tissue of origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/14011—Details ssDNA Bacteriophages
    • C12N2795/14111—Inoviridae
    • C12N2795/14121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
AU49946/00A 1999-05-10 2000-05-10 Bacteriophage isolated from bacterial genomes and extrachromosomal elements and methods of use thereof Abandoned AU4994600A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13337399P 1999-05-10 1999-05-10
US60133373 1999-05-10
PCT/US2000/012580 WO2000067784A1 (en) 1999-05-10 2000-05-10 Bacteriophage isolated from bacterial genomes and extrachromosomal elements and methods of use thereof

Publications (1)

Publication Number Publication Date
AU4994600A true AU4994600A (en) 2000-11-21

Family

ID=22458302

Family Applications (1)

Application Number Title Priority Date Filing Date
AU49946/00A Abandoned AU4994600A (en) 1999-05-10 2000-05-10 Bacteriophage isolated from bacterial genomes and extrachromosomal elements and methods of use thereof

Country Status (2)

Country Link
AU (1) AU4994600A (en)
WO (1) WO2000067784A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2370770B (en) * 2001-01-03 2005-06-01 Simon Connolly Uses of Streptococcus Vaccines
CA2774335C (en) 2009-09-16 2016-10-18 Gotovax Ab Vaccine against cholera and enterotoxigenic e. coli (etec) diarrhea

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5834278A (en) * 1996-05-01 1998-11-10 The Rockefeller University Bacterial peptide methionine sulfoxide reductase an adhesion-associated protein, and antibiotic therapies based thereon

Also Published As

Publication number Publication date
WO2000067784A1 (en) 2000-11-16

Similar Documents

Publication Publication Date Title
AU4520801A (en) Novel substituted phenanthridinones and methods of use thereof
AU2002220277A1 (en) Environment resistant retaining wall block and methods of use thereof
AU3867400A (en) Methods of using bioelastomers
AU2002225954A1 (en) Dipeptidylpeptidases and methods of use
AU2001244109A1 (en) Closure of bacterial ghosts
AU1890599A (en) Novel microorganism and use thereof
AU715620C (en) Therapeutic methods and uses
AU8967998A (en) Antibiotic-ligand conjugates and methods of use thereof
AU4819899A (en) Coupling half and method of making same
AU2001288972A1 (en) Antipsychotic sulfonamide-heterocycles, and methods of use thereof
AU8037900A (en) Modular processing devices and methods of use
AU2001286852A1 (en) Quinoline antibacterial compounds and methods of use thereof
AU2962400A (en) Cleaner composition and method of use thereof
AU5597500A (en) Streptavidin expressed gene fusions and methods of use thereof
AU4994600A (en) Bacteriophage isolated from bacterial genomes and extrachromosomal elements and methods of use thereof
AU2001271400A1 (en) Bioelastomer nanomachines and biosensors
AU2001261496A1 (en) Luxo-sigma54 interactions and methods of use
AU3311800A (en) Detection of bacterial infection
AU1894601A (en) Novel gene and use thereof
AU4839100A (en) Methods of using and compositions comprising n-desmethylzolpidem
AU2001268053A1 (en) Human sparc-homologous (hsparc-h1) gene and methods and uses thereof
AU4176200A (en) Novel genetic suppressor elements and methods of making the same
AUPQ760400A0 (en) Herbical formulations and methods of use thereof
AU3793701A (en) Methods of identifying optimal drug combinations and compositions thereof
AU3976900A (en) Combination of p53 gene and e1b-deleted p53 gene

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase